ICOS+ Th cells produce distinct cytokines in different mucosal immune responses
✍ Scribed by Kerstin Bonhagen; Oliver Liesenfeld; Miguel J. Stadecker; Andreas Hutloff; Klaus Erb; Anthony J. Coyle; Martin Lipp; Richard A. Kroczek; Thomas Kamradt
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 324 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
T cell activation, differentiation and effector functions depend on signals delivered through the antigen‐specific TCR and non‐clonal costimulatory receptors on the T cell. Activated T cells express the inducible costimulator (ICOS). We examined the co‐expression of ICOS with Th cytokines in mucosal immune responses. ICOS^+^CD4^+^ Th cells expressed strikingly different cytokines depending on the type of infection encountered and the cells' anatomical localization. In the Th2‐dominated response to Schistosoma mansoni, ICOS expression of CD4^+^ cells isolated from the liver was strongly associated with the expression of IL‐5, IL‐10, IL‐13, and T1/ST2, but not with the chemokine receptor CXCR5, a pattern consistent with Th2 effector cells. In the secondary lymphatic organs of schistosome‐infected mice, ICOS expression was randomly correlated with Th2 effector‐cytokines, but positively correlated with CXCR5 expression; a pattern consistent with follicular Th cells. In Th cells isolated from gut or liver of mice infected with Toxoplasma gondii, ICOS expression was positively correlated with IFN‐γ production. Finally, in the severe combined immunodeficiency transfer colitis model, ICOS expression was strongly positively associated with IFN‐γ and IL‐2. Thus, ICOS appears to costimulate distinct effector functions in different immune responses, depending on factors such as the nature of the antigen encountered and localization and chronicity of the immune response.
📜 SIMILAR VOLUMES
Direct delivery of the herpes simplex virus thymidine kinase (HSVtk) gene, in combination with the prodrug ganciclovir (GC), has been used for the treatment of localised, inoperable tumours. Several groups have shown that when rodent tumours are ablated in vivo with suicide genes, anti-tumour immuni
## Abstract ## Background CGβ is expressed not only in placenta, but also in a wide range of tumors. To study DNA vaccine based on xenogeneic CGβ for cancer immuno‐therapy, we investigated whether rhesus monkey CGβ (rmCGβ) DNA vaccine could induce protective T‐cell responses and humoral responses